Business Issues/Benchmarks: Page 9

SNDL Reports Q4 and Full Year 2024 Financial and Operational Results

The company reported record full-year net revenue, gross profit and gross margin, as well as positive cash flow and free cash flow.

DeFloria Achieves Ground-Breaking Milestone in Botanical Drug Development

In ‘huge first,’ systemically absorbed oral cannabinoid AJA001 from Charlotte’s Web genetics receives FDA clearance for Phase 2 clinical trials.

Wana Brands Brings Hemp-Derived THC Edibles to Texas

The edibles provider launched its delta-9 THC gummies as the state’s lieutenant governor is pushing legislation to ban intoxicating hemp products.

World Leaders Vote to Ban HHC, List as Schedule II Drug

The UN Commission on Narcotic Drugs approved a recommendation to include the cannabinoid in the 1971 Convention on Psychotropic Substances.

California Department of Cannabis Control Announces Regulatory Reforms

The department’s cannabis cultivation regulatory package is designed to streamline administration and strengthen consumer protection.

Ascend Wellness Reports $562 Million in 2024 Revenue

The cannabis company also reported its second full year of positive cash from operations and positive free cash flow.

The Cannabist Co. Reports $459 Million in 2024 Revenue

The cannabis company continues to complete divestitures, reduce operating and overhead costs, and refine its inventory assortment.

New Mexico Bill to Provide Health Insurance for Medical Cannabis Advances

The legislation could further the argument that cannabis has currently accepted medical use despite federal prohibition in the U.S.

Green Thumb Unveils 3rd Annual Social Impact Report

The cannabis company’s ‘Growing For Good’ program focused on community, inclusion, restorative justice and the environment.

Cresco Labs’ Disciplined Strategy Drives Record Cash Flow in 2024 Financial Results

The cannabis company reported $132 million in operating cash flow for the full year, representing a 126% increase from 2023.

Jushi Holdings Reports $257.5 Million in 2024 Revenue

The cannabis company increased its quarterly and annual operational cash flow compared to prior periods.

The Cannabist Co. Achieves 70% Support For Agreement to Extend Senior Secured Notes Maturity Date

The cannabis company announced that additional holders of issued the Senior Notes entered into joinders to the definitive support agreement.

Previous Page

Page 9 of 516

Next Page